雷达51
生物
泛素
DNA修复
DNA损伤
基因组不稳定性
癌变
下调和上调
细胞生物学
同源重组
泛素连接酶
突变
拉明
癌症研究
核定位序列
DNA
泛素结合酶
核蛋白
赖氨酸
范卡
泛素蛋白连接酶类
细胞核
分子生物学
遗传学
核出口信号
BRCA2蛋白
核运输
HEK 293细胞
信号转导
蛋白质降解
DNA结合蛋白
蛋白酶体
同源染色体
平方毫米
作者
Xiaojuan Yang,Xiaojuan Yang,Ying Zhou,Qing Huang,Lingli Wang,Xicheng Zhang,X Yang,X Yang,L Qiu,Yang Meng,Hong Wu,Bo Zhang,Kunlin Xie,Junhong Han,Qing Zhu
出处
期刊:Oncogene
[Springer Nature]
日期:2026-06-20
标识
DOI:10.1038/s41388-026-03856-z
摘要
Dysregulation of Speckle-type POZ protein (SPOP) and cargo receptor p62/SQSTM1 impairs homologous recombination (HR)-mediated DNA repair by destabilizing RAD51 and FLNA, yet their mechanistic interplay in genomic stability and oncogenesis remains unclear. In this study, we found that the interaction between SPOP and p62/SQSTM1 is obviously enhanced in nucleus in response to DNA damage. Moreover, the nuclear ubiquitination of p62/SQSTM1 at lysine 7 by SPOP led to its degradation, resulting in upregulation of RAD51 and FLNA, RAD51 foci formation, and HR efficiency. In addition, patients-derived p62/SQSTM1 mutations in SPOP-binding consensus (SBC) motif (S276Y/S277G/S277I) increased radiotherapy sensitivity in vitro and in vivo, which attributes to HR deficiency caused by increased degradation of RAD51 and FLNA proteins, and decreased RAD51 and γ-H2AX foci formation. Our finding provides insight into the regulation of HR by SPOP and p62/SQSTM1, and disrupting the interaction between SPOP, p62/SQSTM1 and nuclear ubiquitination may be a potential approach for overcoming radiotherapy resistance in cancer.
科研通智能强力驱动
Strongly Powered by AbleSci AI